Aaron G.L. Fletcher
InvestorManaging Partner at Bios Partners
Fort Worth, Texas
Writes $100K β $5M checks Β· typically $1.5M
FoundedActuate TherapeuticsLung TherapeuticsONL Therapeutics
About
Managing director of Bios Partners and founder/president of Bios Research, providing healthcare public equity research. Holds a PhD in biochemistry from Colorado State University and is a visiting professor at Dallas Baptist University with 10+ years in biotech/healthcare equity consulting.
Experience
- AbiliTech MedicalBoard Membercurrent2017 β present
- Cognition TherapeuticsBoard Membercurrent2015 β present
- Actuate TherapeuticsBoard Membercurrent2015 β present
- Bios PartnersFounder & General Partnercurrent2014 β present
- Lung Therapeutics, Inc.Board Membercurrent2014 β present
- Bios Research, LLCFounder and Presidentcurrent2012 β present
- Dallas Baptist UniversityVisiting Professor of Biochemistrycurrent2008 β present
- UT Southwestern Medical CenterPostdoctoral Fellow2008Dallas/Fort Worth Area
- Colorado State UniversityPHD Candidate2004 β 2007
- York CollegeLaboratory Assistant1999 β 2003
Education
- Colorado State UniversityDoctor of Philosophy - PhD, Biochemistry
- York University - NebraskaBachelors of Science
Skills & more
From Aaron's professional profile.
Same school
Also attended Colorado State University29
+ 23 more
Shared employers
Also worked at Cognition Therapeutics1
Also worked at Dallas Baptist University1
Also worked at UT Southwestern Medical Center14
+ 8 more
Also worked at Colorado State University6
Deals Β· 3
Actuate TherapeuticsBoard seat
via Bios Partners Β· filed Mar 2024 Β· $5M raise
Cue BiopharmaBoard seat
via Bios Partners Β· filed Nov 2022 Β· $30M raise
Lung TherapeuticsBoard seat
via Bios Partners Β· filed Apr 2022 Β· $15M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at Bios Partners
Network7
Investors connected to Aaron in public investor directories β a warm-intro map.

























